Correlation Between Dianthus Therapeutics and Vertex Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dianthus Therapeutics and Vertex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dianthus Therapeutics and Vertex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dianthus Therapeutics and Vertex Pharmaceuticals, you can compare the effects of market volatilities on Dianthus Therapeutics and Vertex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dianthus Therapeutics with a short position of Vertex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dianthus Therapeutics and Vertex Pharmaceuticals.

Diversification Opportunities for Dianthus Therapeutics and Vertex Pharmaceuticals

  Correlation Coefficient

Good diversification

The 3 months correlation between Dianthus and Vertex is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Dianthus Therapeutics and Vertex Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vertex Pharmaceuticals and Dianthus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dianthus Therapeutics are associated (or correlated) with Vertex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vertex Pharmaceuticals has no effect on the direction of Dianthus Therapeutics i.e., Dianthus Therapeutics and Vertex Pharmaceuticals go up and down completely randomly.

Pair Corralation between Dianthus Therapeutics and Vertex Pharmaceuticals

Given the investment horizon of 90 days Dianthus Therapeutics is expected to under-perform the Vertex Pharmaceuticals. In addition to that, Dianthus Therapeutics is 1.1 times more volatile than Vertex Pharmaceuticals. It trades about -0.15 of its total potential returns per unit of risk. Vertex Pharmaceuticals is currently generating about -0.09 per unit of volatility. If you would invest  36,933  in Vertex Pharmaceuticals on September 2, 2023 and sell it today you would lose (1,436) from holding Vertex Pharmaceuticals or give up 3.89% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
ValuesDaily Returns

Dianthus Therapeutics  vs.  Vertex Pharmaceuticals

Dianthus Therapeutics 

Dianthus Performance

0 of 100
Over the last 90 days Dianthus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Dianthus Therapeutics is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.
Vertex Pharmaceuticals 

Vertex Performance

2 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Vertex Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Vertex Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Dianthus Therapeutics and Vertex Pharmaceuticals Volatility Contrast

   Predicted Return Density   

Pair Trading with Dianthus Therapeutics and Vertex Pharmaceuticals

The main advantage of trading using opposite Dianthus Therapeutics and Vertex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dianthus Therapeutics position performs unexpectedly, Vertex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vertex Pharmaceuticals will offset losses from the drop in Vertex Pharmaceuticals' long position.
The idea behind Dianthus Therapeutics and Vertex Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Find actively traded Exchange Traded Funds (ETF) from around the world
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Global Correlations
Find global opportunities by holding instruments from different markets
Bonds Directory
Find actively traded corporate debentures issued by US companies
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
List of equity sectors categorizing publicly traded companies based on their primary business activities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities